跳至主要内容
临床试验/NCT03240003
NCT03240003
暂停
不适用

A Novel Computer-Based Therapy for Social Anxiety

New York State Psychiatric Institute1 个研究点 分布在 1 个国家目标入组 60 人2017年8月25日

概览

阶段
不适用
干预措施
GC-MRT
疾病 / 适应症
Social Anxiety Disorder
发起方
New York State Psychiatric Institute
入组人数
60
试验地点
1
主要终点
Liebowitz Social Anxiety Scale
状态
暂停
最后更新
2个月前

概览

简要总结

The present study is a double blind trial that seeks to examine the feasibility, acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy (GC-MRT) in individuals with social anxiety disorder (SAD)

详细描述

The present study is a double blind trial that seeks to examine the feasibility, acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy (GC-MRT) in individuals with social anxiety disorder (SAD). The purpose of this study is to assess whether a brief computer-based research treatment, provided in 30 minutes sessions twice a week for 4 weeks, helps improve social anxiety symptoms, and by what mechanism. The study will also assess the effect of research treatments on brain activity using a scan called magnetic resonance imaging (MRI).

注册库
clinicaltrials.gov
开始日期
2017年8月25日
结束日期
2026年12月1日
最后更新
2个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Principal Investigator
主要研究者

Franklin Schneier

Research Scientist

New York State Psychiatric Institute

入排标准

入选标准

  • Males and females between the ages of 18 and 60
  • Current DSM-V primary diagnosis of SAD
  • Score of at least 50 on the Liebowitz Social Anxiety Scale (Self-rated version)
  • Fluent in English and willing and able to give informed written consent and participate responsibly in the protocol
  • Normal or corrected-to-normal vision

排除标准

  • Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder
  • Current severe depression
  • Suicidal ideation or behavior
  • Current diagnosis of PTSD, obsessive-compulsive disorder, bipolar disorder, manic episode or tic disorder
  • Current or past organic mental disorder, seizure disorder, epilepsy or brain injury
  • Current unstable or untreated medical illness
  • Severe alcohol use disorder, severe cannabis use disorder, and any severity of other substance use disorder (except nicotine use disorders allowed)
  • Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs) for a least 3 months
  • Any concurrent cognitive behavioral therapy; other psychotherapy that was initiated in the past 3 months
  • Pregnancy, or plans to become pregnant during the period of the study - will be assessed by Urine β-HCG

研究组 & 干预措施

GC-MRT

Group 1 will receive a 4-week (8-sessions) course of standard GC-MRT

干预措施: GC-MRT

non-GC-MRT

Group 2 will receive a 4-week (8-sessions) course of non-GC-MRT

干预措施: Non-GC-MRT

GC-MRT-modified

Group 3 will receive a 4-week (8-sessions) course of modified GC-MRT.

干预措施: modified GC-MRT

结局指标

主要结局

Liebowitz Social Anxiety Scale

时间窗: 4 months

Total score of the Liebowitz Social Anxiety Scale

次要结局

  • Social Phobia Inventory (SPIN)(4 months)
  • Revised Social Anhedonia Scale(4 months)
  • Snaith Hamilton Pleasure Scale(4 months)
  • Quality of Life Enjoyment & Satisfaction Questionnaire(4 months)
  • Clinical Global Impression-Change Scale(4 months)
  • Hamilton Rating Scale for Depression - 17 item version(4 months)

研究点 (1)

Loading locations...

相似试验